I
mproper clearance of dying cells by activated neighboring phagocytes contributes to the establishment and progression of numerous human diseases. As a consequence, efferocytosis-dependent efficient repair is critical to sustain tissue homeostasis by directing the healing of injured tissues through active removal of apoptotic or necrotic cells out of the milieu. 
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Cellular necrosis and apoptosis in the acute inflammatory phase of myocardial infarction (MI) are integral components of tissue remodeling and should be dealt with appropriately to improve tissue healing and recovery. 2, 3 The externalization of phosphatidylserine on the outer leaflet of the injured cell membrane is one of the earliest signals sufficient to activate the phagocytotic process. The recognition of cells exposing phosphatidylserine is mediated by a few receptors, among Background-In infarcted heart, improper clearance of dying cells by activated neighboring phagocytes may precipitate the transition to heart failure. We analyzed the coordinated role of 2 major mediators of efferocytosis, the myeloid-epithelialreproductive protein tyrosine kinase (Mertk) and the milk fat globule epidermal growth factor (Mfge8), in directing cardiac remodeling by skewing the inflammatory response after myocardial infarction. Methods and Results-We generated double-deficient mice for Mertk and Mfge8 (Mertk /Mfge8 −/− bone marrow chimeras manifested increased accumulation of apoptotic cells, enhanced fibrotic area, and larger infarct size, as well as reduced angiogenesis. We found that the abrogation of efferocytosis affected neither the ability of circulating monocytes to infiltrate cardiac tissue nor the number of resident Ly6C
High and Ly6C How monocytes/macrophages populating the infarcted milieu. In contrast, combined Mertk and Mfge8 deficiency in Ly6C High 
/Ly6C
Low monocytes/macrophages either obtained from in vitro differentiation of bone marrow cells or isolated from infarcted hearts altered their capacity of efferocytosis and subsequently blunted vascular endothelial growth factor A (VEGFA) release. Using LysMCre which myeloid-epithelial-reproductive receptor tyrosine kinase (Mertk) and milk fat globule epidermal growth factorlike factor 8 (Mfge8) are upregulated during inflammation and play nonredundant roles. Mertk receptor on phagocytes recognizes apoptotic cells by bridging Gas6 and protein S, which directly interact with phosphatidylserine. 4, 5 Mfge8 is a secretory glycoprotein containing C domains that interact with anionic phospholipids and extracellular matrixes, as well as epidermal growth factor-like domains with an RGD motif that binds integrin α v β 3 and α v β 5 . 6 Thus, Mfge8 appears to be instrumental in cell-cell interactions and has been involved in diverse physiological functions, including fertilization, 7 angiogenesis, 8 atherosclerosis, 9 or innate immunity, through inhibition of inflammasome-induced interleukin (IL)-1β production. 10 One of the prominent functions of Mfge8 is also to link phosphatidylserine of dying cells to integrin α v β 3 and α v β 5 of phagocytic cells. [11] [12] [13] Although the clearance of apoptotic debris by Mertk and Mfge8 has been characterized independently in different pathological settings, whether they also coordinate their functions has not been explored yet. We hypothesized that Mertk and Mfge8 play a critical role in synchronizing efferocytosis within the cardiac tissue after MI and subsequently orchestrate cardiac remodeling.
During the inflammatory reaction, 2 sequential phases defined by the expression of Ly6C on monocytes/macrophages can be identified in the infarcted myocardium. 14, 15 The inflammatory Ly-6C
High monocyte subset is recruited during the first days after MI, but their number is reduced from day 5 onward, when inflammation resolves in the cardiac wound. Starting at approximately day 3 after MI, the infarct tissue accumulates Ly-6C
Int/Low monocytes. The inflammatory Ly-6C High monocyte subset can drive robust inflammation, leading to pathological remodeling, whereas Ly-6C Int/Low monocytes/macrophages seem to promote reparative activities, including angiogenesis. 14, 15 However, both monocyte subsets are required for adequate cardiac repair because ablation of each subpopulation is sufficient to disturb the healing process.
14 Many of these monocytes may either die or exit the cardiac tissue, whereas surviving monocytes populating the ischemic milieu may acquire a macrophage phenotype with M1-or M2-like activation mode associated with specific functions in the resolution of inflammation, tissue repair, and remodeling. 16 Recent works also indicate that the adult heart expands distinct populations of macrophages, including monocyte-derived macrophages and subsets of resident macrophages of embryonic origin, with opposite roles in inflammation and cardiac recovery. [17] [18] [19] [20] How different subsets of monocytes/macrophages can govern distinct patterns of cardiac recovery remains largely unknown. Interestingly, efferocytosis can operate a shift in macrophage activation toward M2-like cells. 21 Along this line, dying tumor cells that are cleared through Mertk-dependent efferocytosis robustly induce the transcription of genes encoding wound-healing cytokines, including IL-4, IL-10, IL-13, and transforming growth factor-β (TGFβ). 22 We reasoned that efficient Mertk-or Mfge8-dependent clearance of dying cardiac cells by tissue monocytes/macrophages dictates their phenotype and is required to fine-tune the reparative process after ischemic cardiac injury. Here, we show that efferocytosis-related signaling commands vascular endothelial growth factor (VEGF) A release by monocytes/ macrophages and limits adverse left ventricular remodeling after MI. 
Methods

Animals
Myocardial Infarction
Mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg) via intraperitoneal injection and then intubated and ventilated with air with a small-animal respirator (Harvard Apparatus, Courtaboeuf, France). The chest wall was shaved, and a thoracotomy was performed in the fourth left intercostal space. The left ventricle was visualized; the pericardium was then removed; and the left anterior descending artery was permanently ligated with a 7-0 monofilament suture (Peters Surgical, Bobigny, France) at the site of its emergence from under the left atrium, as previously described. 26, 27 Significant blanching at the ischemic area was considered indicative of successful coronary occlusion. The thoracotomy was closed with four 6-0 monofilament sutures. The endotracheal tube was removed once spontaneous respiration resumed, and animals were placed on a warm pad maintained at 37°C until they were completely awake.
Bone Marrow Transplantation
Bone marrow (BM) cells were obtained by flushing tibiae and femora of donor mice, as described above. WT mice were lethally irradiated with a total dose of 9.5 Gy and were intravenously injected 24 hours later with 1×10 7 
Echocardiography
The left ventricular function was assessed by transthoracic echocardiography with a VEVO2100 Biomicroscope (Visualsonics). Mice were anesthetized with isoflurane (1.5% in air), shaved with the use of depilatory cream, and placed on a dedicated eating plate in the supine position, allowing monitoring of respiratory frequency and temperature. Parasternal long-axis views of the left ventricle were obtained with a 40-MHz ultrasound probe (MS550D) at a frame rate between 180 and 240 frames per second. Measurements were performed offline with the Advanced Cardio Package of the VEVO2100 software. Endocardium contours were drawn from telesystolic and telediastolic long-axis views; left ventricular end-diastolic and -systolic volumes and ejection fraction were then measured.
Immunohistochemical Analysis
Fourteen days after MI, hearts were perfused with PBS. Left ventricles were mounted in Cryomatrix (Thermo Scientific) and dropped into frozen isopentane. Sections (7 μm) were cut. For evaluation of apoptosis, heart sections were stained with terminal deoxynucleotidyl transferase dUTP nick-end labeling technology kit (Roche Diagnostics, Meylan, France) according to the manufacturer's instructions. Masson trichrome and Red Sirius stainings were March 1, 2016 performed to analyze infarct size and collagen content, respectively. Infarct size was expressed as the ratio of endocardial left ventricular scar length to the total endocardial left ventricular length. Collagen content and the number of capillaries were quantified in the border zone of the infarct scar on a Axioimager Carl Zeiss microscope. Collagen content was measured as the ratio of the total area stained by Red Sirius to the total area of the tissue section on the Image J software. Capillaries were stained with TRITC-conjugated Griffonia simplicifolia lectin (Sigma-Aldrich, Evry, France) and cardiomyocyte membranes with FITC-conjugated wheat germ agglutinin lectin (Sigma-Aldrich). Results were expressed as the ratio of capillaries number to cardiomyocytes.
Immunohistochemical VEGFA Staining on Macrophages
Five days after MI, hearts were perfused with PBS. Left ventricles were mounted in Cryomatrix (Thermo Scientific) and dropped into frozen isopentane. Sections (7 μm) were cut. Heart sections were fixed with 4% paraformaldehyde for 10 minutes at room temperature, stained with TRITC-conjugated wheat germ agglutinin lectin for 1 hour at room temperature, washed with PBS, permeabilized with 0.25% Triton X100 in PBS, washed with PBS, blocked for 30 minutes at room temperature in 5% donkey serum in PBS, stained 2 hours at room temperature with anti-VEGFA (Abcam, Cambridge, Great Britain), washed with PBS, stained 1 hour at room temperature with FITC donkey anti-rabbit IgG, washed with PBS, stained overnight with anti-CD68 (AbD Serotec, Bio-Rad, Kidlington, Oxford, UK) at 4°C, washed with PBS, and stained with Cy5 donkey anti-rat IgG for 1 hour at room temperature. Slides were mounted with DAPI and Mowiol. Images were acquired on a Leica SP8 confocal microscope. 
Injection of BM Mononuclear Cells
Cardiac Efferocytosis
To unravel in vivo cardiac efferocytosis, cardiac α-actin-GFP mice with constitutive expression of GFP in cardiomyocytes were lethally irradiated with a total dose of 9.5 Gy and intravenously injected 24 hours later with 1×10 7 total BM cells isolated from WT or double-knockout Mertk −/− /Mfge8 −/− animals. MI was induced 10 weeks after BM reconstitution. Three days after MI, cardiac mononuclear cells were isolated as described above and stained. Events were acquired on ImageStream (Amnis Corp) and analyzed on Ideas software. The amount of efferocytosis was determined as the percentage of GFP-positive cells among the population of Ly6C
High/Low monocytes/macrophages.
Flow Cytometry Analysis
At 1, 3, 5, 7, and 10 days after MI, hearts were perfused with PBS. Left ventricles were harvested; minced with fine scissors; placed into a cocktail of collagenase I (450 U/mL), collagenase XI (125 U/mL), DNase I (60 U U/mL), and hyaluronidase (60 U/mL; Sigma-Aldrich); and shaken at 37°C for 1 hour, as previously described. 27 Cells were then triturated through a nylon mesh (40 μm) and centrifuged (10 minutes, 400g, 4°C). Mononuclear cells were purified by density centrifugation with Ficoll (Histopaque-1083, Sigma-Aldrich; 25 minutes, 400g, room temperature). The resulting cell suspensions were washed with PBS, and total leukocyte numbers were determined. Cells harvested from the hearts were stained in PBS at 4°C with the following antibodies: efluor450-conjugated anti-CD11b (M1/70, Biolegend), phycoerythrin-conjugated anti-Ly6G (1A8, BD Pharmingen, Le Pont de Claix, France), phycoerythrin-conjugated anti-NK-1. . The total number of cells was then normalized to heart weight. Events were acquired on an LSR II flow cytometer (BD Biosciences), and results were analyzed on FlowJo (FlowJo LLC, Ashland, OR).
Protein Expression of Chemokines, Cytokines, and Growth Factors in the Cardiac Tissue
At 1, 3, 5, 7, and 10 days after MI, the upper part of the left ventricle was harvested and homogenized in Tris EDTA NaCl buffer (1 mmol/L EDTA, 10 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 10 mg/mL NP40 with antiprotease cocktail; Roche Diagnostics, Meylan, France). Protein concentration was assessed by Lowry assay, and sample concentrations were normalized before quantification of proteins. CCL2, CCL7, IL-1β, IL-6, IL-10, IL-12, IL-13, and tumor necrosis factor-α were quantified with Flowcytomix (ebiosciences, Paris, France) according to the manufacturer's instructions. VEGFA and TGFβ were quantified by ELISA (R&D Systems Europe, Lille, France) according to the manufacturer's instructions.
In Vitro Generation of BM-Derived Macrophages
BM cells were flushed from tibias and femora, washed in PBS with 1% FBS, and cultured in macrophage growth medium for 7 days (RPMI 1640 Glutamax, Fisher Scientific, Illkirsh, France) supplemented with 10% heat-inactivated FCS, 15% L929 medium, and 100 U/mL penicillin/streptomycin. Macrophages were then activated for an additional 24 hours with 1 μg/mL lipopolysaccharide (LPS) and 100 U/mL interferon-γ (IFNγ), 10 ng/mL IL-4, or 10 ng/mL IL-10 (R&D Systems Europe). After 24 hours, the medium was removed, and RPMI 1640 Glutamax supplemented with 10% FCS and 100 U/ mL penicillin/streptomycin (complete RPMI medium) was added for 24 hours. Supernatants were harvested for ELISA assays, and cells were washed 3 times in cold PBS and resuspended in RNeasy Lysis Buffer (Rneasy Micro Kit, Qiagen, Courtaboeuf, France). RNA was extracted according to the manufacturer's instructions.
In Vivo Phagocytosis Assay
Phagocytosis by inflammatory macrophages was evaluated by injecting 1×10 7 apoptotic thymocytes or PBS alone (control without phagocytosis) 72 hours after the initial peritoneal injection of thioglycolate (3%; BBL Thioglycolate Medium, brewer modified, BD Biosciences). Three hours after injection, 1 mL PBS was injected into the peritoneum and collected. Peritoneal lavage fluid was centrifuged. Supernatants were harvested and frozen before VEGFA quantification. To evaluate the amount of efferocytosis by flow cytometry, cells were collected and stained with the following antibodies: Alexa 488-conjugated anti-CD11b and V450-conjugated anti-Ly6G (BD Biosciences). The amount of efferocytosis by monocytes/macrophages was expressed as arbitrary fluorescence unit.
Statistical Analysis
Results are expressed as mean±SEM. Kruskal-Wallis 1-way ANOVA was used to compare each measure when there were ≥3 independent groups. Comparisons between groups were performed with Dunn multiple-comparisons test when the ANOVA test was statistically significant. A value of P<0.05 was considered significant. The MannWhitney test was used to compare 2 groups.
Results
Mertk and Mfge8 Coordinately Improve Cardiac Remodeling After MI
To decipher the respective roles of the 2 major phagocytic proteins Mertk and Mfge8 in cardiac homeostasis, we used −/− animals compared with WT mice (P<0.05, Mann-Whitney U test; Figure 1B) .
Together, these data indicate a central cooperative role for Mertk-and Mfge8-dependent signaling in the control of cardiac remodeling and the recovery of heart function after MI.
Myeloid-Derived Mertk and Mfge8 Improve Remodeling After MI
Because professional phagocytes mainly express Mertk and Mgfe8, we first identified the type of inflammatory cells expressing these proteins in the infarcted heart. Using cells sorted by fluorescence-activated cell sorter, we showed that Mertk and Mfge8 mRNA levels were detected mainly in cardiac Ly6C
High and Ly6C We next sought to understand the mechanisms underlying the influence of myeloid-derived Mertk and Mfge8 in cardiac remodeling after MI, focusing on the double-deficiency context.
We first assessed the extent of efferocytosis of dead cardiomyocytes in the infarcted heart using transgenic mice, in which expression of GFP is under control of the cardiac α-actin promoter (α-actin-GFP + ). 25 We next hypothesized that a reduction in efferocytosis and a subsequent increase in apoptotic cell number may have altered the number of specific subpopulations of inflammatory cells in the myocardium: cardiac neutrophils and cardiac monocytes/macrophages, which are major players in the setting of MI. Using fluorescence-activated cell sorter analysis of cardiac tissue, we demonstrated that the number of neutrophils was unchanged between WT mice lethally irradiated and transplanted with Mertk −/− /Mfge8 −/− BM and those transplanted with WT BM (Figure 3B ). In the mouse, circulating monocytes are phenotypically and functionally heterogeneous and can be separated according to Ly6C expression. 29, 30 We showed that the number of cardiac Ly6C
High and Ly6C Low monocytes (CD45 High monocytes in the infarcted heart gives rise to distinct population of F4/80-expressing macrophages. 31 However, as for the monocytes subsets, the amount of Ly6C
High and Ly6C 
Ly-6C
High monocytes and macrophages in an M1-like activation mode release high amounts of inflammatory cytokines and proteases. During the following rebuilding phase, the inflammatory activity resolves and gives way to Ly-6C Int/Low monocytes/macrophages. These cells may release VEGFA, TGFβ, and IL-10, supporting angiogenesis, collagen production, and inflammation resolution. We therefore evaluated those modulators of cardiac remodeling in our experimental conditions. Protein levels of IL-1β, IL-6, IL-12, IL-13, tumor necrosis factor-α, and TGFβ were unchanged in the cardiac tissue of WT mice lethally irradiated and transplanted with Mertk 
Mfge8
−/− BM chimeras compared with controls ( Figure 4A) .
From these data, we postulated that an alteration in cardiac VEGFA and IL-10 protein levels might be related to a reduction in the ability of cardiac monocytes/macrophages to release these factors. We first showed that CD68-positive cells expressed VEGFA in the infarcted heart (Figure IV in the online-only Data Supplement). We then used fluorescenceactivated cell sorter to sort Ly6C
High and Ly6C Low monocytes/ macrophages from hearts 3 days after infarction. Next, we examined VEGFA and IL-10 expression by quantitative polymerase chain reaction. VEGFA mRNA levels were smaller in sorted Ly6C High In response to various signals, macrophages may balance between the M1-and M2-like modes. We speculated that Mertk/ Mgfe8 signaling might modulate macrophage activation state and their ability to release VEGFA. To examine this hypothesis, macrophages were differentiated in vitro from cultured BM isolated from WT or Mertk −/− /Mfge8 −/− animals and activated with cytokines to trigger various inflammatory profiles. LPS/IFNγ elicited the M1-like mode, whereas IL-4 and IL-10 treatments induced M2-like macrophages. 32 Mfge8 and Mertk were expressed in all types of WT BM-derived macrophages and were not detected in Mertk
−/− BM-derived macrophages ( Figure 5A) . Notably, treatment with IL-4 heightened both Mertk and Mfge8 mRNA levels compared with LPS+IFNγ or IL-10 stimulation ( Figure 5A ). Results also showed that macrophage activation was achieved in these in vitro conditions; that is, mRNAs of the M1 markers (Cox2 and NOS2) were strongly expressed in WT macrophages treated with both LPS and IFNγ, whereas the M2 markers mRNAs 
−/− BM-derived macrophages compared with WT cells (Figure 5D ).
Finally, we assessed the putative causal link between Mertk/Mfge8-dependent efferocytosis and VEGFA release. We injected 1×10 7 R18-labeled apoptotic thymocytes in WT mice lethally irradiated and transplanted with WT BM or Mertk (Figure 6C ).
Taken together, these findings identify a role for Mertkand Mfge8-dependent efferocytosis in promoting an M2 phenotype and in controlling endothelial cell apoptosis and proliferation, at least in part, through the release of VEGFA by macrophages.
Loss of Myeloid Cell-Derived VEGFA Precipitates Adverse Left Ventricular Remodeling After MI
We then hypothesized that loss of myeloid-derived VEGF should recapitulate the effect of Mertk/Mfge8 deficiency on cardiac function and remodeling after MI. We used mice with both alleles of exon Figure 7A ). These effects were associated with superior infarct size and collagen content and a limited number of capillaries in the infarcted hearts of mice reconstituted with VEGF-deficient myeloid cells ( Figure 7B) .
We highlighted that Mertk/Mfge8-related pathways triggered an M2 activation mode in BM-derived macrophages. We postulated that VEGFA deletion in BM-derived macrophages might mimic this phenotype. To examine this hypothesis, macrophages were differentiated in vitro from cultured BM isolated from LysMCre 
Discussion
It is now widely accepted that cardiac remodeling after MI and myeloid cells are intertwined, yet the molecular mechanisms that link monocytes/macrophages to cardiac homeostasis are not well defined. Our results show that efficient Mertk-and Mfge8-dependent clearance of dying cardiac cells by tissue monocytes/macrophages dictates their phenotypes and is critical to the fine-tuning of the reparative process after ischemic cardiac injury. In particular, efferocytosis-related signaling commands VEGFA release by monocytes/macrophages to locally repair the dysfunctional heart. A number of efferocytosis receptors have been identified in macrophages, suggesting that multiple complementary pathways are involved in the efficient clearance of apoptotic cells. Mertk deficiency alone has already been shown to increase the accumulation of apoptotic cardiomyocytes and compromises systolic performance of the infarcted heart. 34 We provide the first evidence that Mfge8 is also engaged in the recognition of dying cells and in the control of cardiac function and remodeling after MI. Mfge8 is known to link phosphatidylserine of dying cells to integrin α v β 3 and α v β 5 of phagocytic cells. [11] [12] [13] Mfge8 supplementation strongly increases efferocytosis by WT and Mertk-deficient retinal pigment epithelium, 13 implying that Mfge8-related signaling may constitute a nonredundant pathway for the clearance of apoptotic cells. However, coexpression of the active form of Mertk with integrin α v β 5 has a synergistic effect on Rac1 activation, lamellipodia formation, and the phagocytosis of apoptotic cells. Gas6 fails to stimulate phagocytosis in β5-deficient cells, suggesting that Mertk is directionally and functionally linked to the Mfge8/ integrin pathway to amplify intracellular signals and to internalize apoptotic cells. 35 In addition, whereas Mertk is broadly expressed by all the different macrophage subpopulations, Mfge8 is essential for the phagocytosis of apoptotic cells by inflammation-activated macrophages. 11, 36 Although the direct or indirect interactions between Mertk and Mfge8 signaling remain to be elucidated, our results clearly indicate that these 2 major phagocytic proteins coordinately participate in tissue homeostasis and recovery from ischemic injury. Cardiac monocyte and macrophage subsets have been shown to control tissue homeostasis through distinct properties. An inflammatory phenotype (Ly6C High monocytes/M1-type macrophages) initially governs robust inflammation, proteolysis of the extracellular matrix, and clearance of dead cells, a prerequisite for replacing the infarcted milieu with granulation tissue. During the following phase, cells with a lesser inflammatory phenotype (Ly6C Int/Low monocytes/M2-type macrophages) dominate and are thought to release VEGF and TGFβ, supporting angiogenesis and collagen production. 15, 17 In our experiments, Mertk and Mfge8 deletion in BM had no effect on the tissue levels of the major chemoattractant molecules, on the recruitment of circulating inflammatory cells, on the accumulation of monocytes, and on the number of circulating monocytederived or tissue-resident macrophages within the ischemic myocardium. Hence, the pathophysiological outcome of Mertk and Mfge8 deletion was not related to a defective recruitment or accumulation of inflammatory cells but likely relied on monocyte/macrophage skewing from an inflammatory to a reparative state. In vitro, Mertk and Mfge8 switch macrophages toward an M2-like mode and control the ability of IL-4-or IL-10-treated BM-derived macrophages to release VEGFA. Along this line, we unveiled a role for IL-4 activation in promoting the expression of both Mertk and Mfge8 in cultured BM-derived macrophages, potentially initiating a positive feedback loop to sustain an M2-like phenotype. Mertk-and Mfge8-dependent engulfment of apoptotic cells commands VEGFA release by targeted monocytes/macrophages and shapes endothelial cells proliferation and apoptosis. Therefore, it is tempting to speculate that efficient Mertk-and Mfge8-dependent efferocytosis participates in the transition of cardiac phagocytes from an inflammatory to a VEGFA-related reparative phenotype. However, one cannot refute the hypothesis that Mertk and Mfge8 concomitant loss may affect other protective mediators. 
